Fluorinated poly(propylenimine) dendrimers as gene vectors

Biomaterials

Volumn 35, Issue 20, 2014, Pages 5407-5413

  Liu, Hongmei ^a   Wang, Yu ^b   Wang, Mingming ^a   Xiao, Jianru ^b   Cheng, Yiyun ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Dendrimer; Fluorination; Gene transfection; Poly(propylenimine)

Indexed keywords

AMINO ACIDS; CYTOTOXICITY; FLUORINATION; FLUORINE; GENE TRANSFER; GENES; HALOGENATION; LIPOSOMES; MOLECULAR BIOLOGY;

GENE DELIVERY VECTORS; GENE TRANSFECTION; LOW CYTOTOXICITIES; MULTICELLULAR SPHEROID; POLY(PROPYLENIMINE); POLYETHYLENEIMINE; SYNTHESIZED MATERIALS; TRANSFECTION REAGENTS;

DENDRIMERS;

AZETIDINE; AZIRIDINE DERIVATIVE; DENDRIMER; FLUOROCARBON;

CHEMISTRY; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; HEK293 CELL LINE; HELA CELL LINE; HUMAN;

AZIRIDINES; DENDRIMERS; FLUOROCARBON POLYMERS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEK293 CELLS; HELA CELLS; HUMANS; TRANSFECTION;

EID: 84899472567     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.03.040     Document Type: Article

References (42)

1. Kanasty R., Dorkin J.R., Vegas A., Anderson D. Delivery materials for siRNA therapeutics. Nat Mater 2013, 12:967-977.
2. Wagner E. Strategies to improve DNA polyplexes for invivo gene transfer: will "artificial viruses" be the answer?. Pharm Res 2004, 21:8-14.
3. Liu X., Liu C., Laurini E., Posocco P., Pricl S., Qu F., et al. Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimer. Mol Pharm 2012, 9:470-481.
4. Posocco P., Liu X., Laurini E., Marson D., Chen C., Liu C., et al. Impact of siRNA overhangs for dendrimer-mediated siRNA delivery and gene silencing. Mol Pharm 2013, 10:3262-3273.
5. Wen Y., Guo Z., Du Z., Fang R., Wu H., Zeng X., et al. Serum tolerance and endosomal escape capacity of histidine-modified pDNA-loaded complexes based on polyamidoamine dendrimer derivatives. Biomaterials 2012, 33:8111-8121.
6. Zhou J., Liu J., Cheng C.J., Patel T.R., Weller C.E., Piepmeier J.M., et al. Biodegradable poly (amine-co-ester) terpolymers for targeted gene delivery. Nat Mater 2012, 11:82-90.
7. Dufès C., Uchegbu I.F., Schätzlein A.G. Dendrimers in gene delivery. Adv Drug Deliv Rev 2005, 57:2177-2202.
8. Kim A.J., Boylan N.J., Suk J.S., Hwangbo M., Yu T., Schuster B.S., et al. Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers. Angew Chem Int Ed Engl 2013, 52:3985-3988.
9. Tomalia D.A. Interview: an architectural journey: from trees, dendrons/dendrimers to nanomedicine. Nanomedicine 2012, 7:953-956.
10. Tomalia D.A. Dendritic effects: dependency of dendritic nano-periodic property patterns on critical nanoscale design parameters (CNDPs). New J Chem 2012, 36:264-281.
11. Tomalia D.A. Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog Polym Sci 2005, 30:294-324.
12. Menjoge A.R., Kannan R.M., Tomalia D.A. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today 2010, 15:171-185.
13. Svenson S., Tomalia D.A. Dendrimers in biomedical applications-reflections on the field. Adv Drug Deliv Rev 2012, 64:102-115.
14. Liu X., Liu C., Catapano C.V., Peng L., Zhou J., Rocchi P. Structurally flexible triethanolamine-core poly (amidoamine) dendrimers as effective nanovectors to deliver RNAi-based therapeutics. Biotechnol Adv 2014, http://dx.doi.org/10/1016/j.biotechadv.2013.08.001.
15. Huang S., Li J., Han L., Liu S., Ma H., Huang R., et al. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma. Biomaterials 2011, 32:6832-6838.
16. Huang R., Ke W., Han L., Li J., Liu S., Jiang C. Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration. Biomaterials 2011, 32:2399-2406.
17. Han L., Huang R., Li J., Liu S., Huang S., Jiang C. Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer. Biomaterials 2011, 32:1242-1252.
18. Liu Y., Huang R., Han L., Ke W., Shao K., Ye L., et al. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Biomaterials 2009, 30:4195-4202.
19. Ke W., Shao K., Huang R., Han L., Liu Y., Li J., et al. Gene delivery targeted to the brain using an angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. Biomaterials 2009, 30:6976-6985.
20. Shan Y., Luo T., Peng C., Sheng R., Cao A., Cao X., et al. Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors. Biomaterials 2012, 33:3025-3035.
21. Helms B., Meijer E. Dendrimers at work. Science 2006, 313:929-930.
22. Dufès C., Keith W.N., Bilsland A., Proutski I., Uchegbu I.F., Schätzlein A.G. Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. Cancer Res 2005, 65:8079-8084.
23. Chisholm E.J., Vassaux G., Martin-Duque P., Chevre R., Lambert O., Pitard B., et al. Cancer-specific transgene expression mediated by systemic injection of nanoparticles. Cancer Res 2009, 69:2655-2662.
24. Shao N., Su Y., Hu J., Zhang J., Zhang H., Cheng Y. Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity. Int J Nanomed 2011, 6:3361-3372.
25. Chen A.M., Taratula O., Wei D., Yen H.-I., Thomas T., Thomas T., et al. Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexes. ACS Nano 2010, 4:3679-3688.
26. Lemarié F., Croft D.R., Tate R.J., Ryan K.M., Dufès C. Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system. Biomaterials 2012, 33:2701-2709.
27. Koppu S., Oh Y.J., Edrada-Ebel R., Blatchford D.R., Tetley L., Tate R.J., et al. Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA. JControl Release 2010, 143:215-221.
28. Kim K., Lei Y., Stolz D., Liu D. Bifunctional compounds for targeted hepatic gene delivery. Gene Ther 2007, 14:704-708.
29. Taratula O., Garbuzenko O.B., Kirkpatrick P., Pandya I., Savla R., Pozharov V.P., et al. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. JControl Release 2009, 140:284-293.
30. Russ V., Günther M., Halama A., Ogris M., Wagner E. Oligoethylenimine-grafted polypropylenimine dendrimers as degradable and biocompatible synthetic vectors for gene delivery. JControl Release 2008, 132:131-140.
31. Klutz K., Russ V., Willhauck M.J., Wunderlich N., Zach C., Gildehaus F.J., et al. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene. Clin Cancer Res 2009, 15:6079-6086.
32. Aldawsari H., Edrada-Ebel R., Blatchford D.R., Tate R.J., Tetley L., Dufès C. Enhanced gene expression in tumors after intravenous administration of arginine-, lysine-and leucine-bearing polypropylenimine polyplex. Biomaterials 2011, 32:5889-5899.
33. Kim T.I., Baek J.U., Zhe Bai C., Park J.S. Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier. Biomaterials 2007, 28:2061-2067.
34. Schatzlein A.G., Zinselmeyer B.H., Elouzi A., Dufes C., Chim Y.T.A., Roberts C.J., et al. Preferential liver gene expression with polypropylenimine dendrimers. JControl Release 2005, 101:247-258.
35. Tziveleka L.-A., Psarra A.-M.G., Tsiourvas D., Paleos C.M. Synthesis and characterization of guanidinylated poly (propylene imine) dendrimers as gene transfection agents. JControl Release 2007, 117:137-146.
36. Mastrobattista E., Hennink W.E. Polymers for gene delivery: charged for success. Nat Mater 2012, 11:10-12.
37. Wang M., Liu H., Li L., Cheng Y. Afluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios. Nat Commun 2014, 5:3053. 10.1038/ncomms4053.
38. Choi J.S., Nam K., Park J.Y., Kim J.B., Lee J.K., Park J.S. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. JControl Release 2004, 99:445-456.
39. Liu H., Wang H., Yang W., Cheng Y. Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost. JAm Chem Soc 2012, 134:17680-17687.
40. Breunig M., Lungwitz U., Liebl R., Goepferich A. Breaking up the correlation between efficacy and toxicity for nonviral gene delivery. Proc Natl Acad Sci U S A 2007, 104:14454-14459.
41. Liu Z., Zheng M., Meng F., Zhong Z. Non-viral gene transfection invitro using endosomal pH-sensitive reversibly hydrophobilized polyethylenimine. Biomaterials 2011, 32:9109-9119.
42. Zheng M., Zhong Y., Meng F., Peng R., Zhong Z. Lipoic acid modified low molecular weight polyethylenimine mediates nontoxic and highly potent invitro gene transfection. Mol Pharmacol 2011, 8:2434-2443.